Coverage of the Interscience Conference on Antimicrobial Agents and Chemotherapy
- Details
- Category: HIV Treatment
- Published on Tuesday, 11 September 2012 00:00
- Written by Liz Highleyman
HIVandHepatitis.com coverage of the 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), San Francisco, September 9-12, 2012.
Topics highlighted this year include experimental antiretroviral drugs, complications related to HIV and its treatment, recent developments in hepatitis C therapy, cancer caused by HPV, influenza, tuberculosis, and STDs.
HIVandHepatitis.com ICAAC 2012 conference section

ICAAC 2012: HIV+ People Have Heart Attacks Younger, Receive Later Care, Die More Often
- Details
- Category: Cardiovascular Disease
- Published on Monday, 10 September 2012 00:00
- Written by Liz Highleyman
People with HIV had heart attacks at a younger age than HIV negative individuals and were about 50% more likely to die after an acute myocardial infarction, according to a study presented this week at the 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2012) in San Francisco. A related analysis found that HIV positive people received coronary catheterization at a later stage, after they had more advanced heart damage.
Coverage of the XIX International AIDS Conference
- Details
- Category: HIV Treatment
- Published on Friday, 27 July 2012 00:00
- Written by Liz Highleyman
HIVandHepatitis.com coverage of the XIX International AIDS Conference (AIDS 2012), July 22-27 in Washington, DC.
Conference highlights include experimental antiretroviral drugs, treatment as prevention and PrEP, scaling up HIV treatment and prevention in resource-limited countries, human rights and concerns of heavily impacted populations, AIDS policy and advocacy, HIV/HBV and HIV/HCV coinfection, and the search for a cure for HIV.
HIVandHepatitis.com AIDS 2012 conference section

ICAAC Meeting Underway in San Francisco -- HIV, HCV, HPV, Flu, and More
- Details
- Category: Cardiovascular Disease
- Published on Sunday, 09 September 2012 13:37
- Written by Liz Highleyman
The 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy -- better known as ICAAC -- opened Sunday, September 9, at San Francisco's Moscone Center.
Reduced Neurotropic Factor May Explain Cognitive Impairment in HIV+ People
- Details
- Category: Neurocognitive Problems
- Published on Tuesday, 17 July 2012 00:00
- Written by Press Release
HIV's gp120 envelope protein appears to interfere with production of a natural compound that promotes connections between neurons in the brain, researchers reported in the July 11, 2012, Journal of Neuroscience. The investigators suggested that this may contribute to neurocognitive problems in people with HIV, and possibly other types of cognitive decline such as senile dementia.
AIDS 2012: HIV+ Men Prone to Bone Fractures at Earlier Age
- Details
- Category: Bone Loss/Osteoporosis
- Published on Tuesday, 21 August 2012 00:00
- Written by Liz Highleyman
HIV positive men in the long-running MACS cohort appeared to sustain osteoporosis-related bone fractures at an earlier age than HIV negative men, researchers reported at the recent XIX International AIDS Conference (AIDS 2012) in Washington, DC. A related study found several factors that predict greater risk of fractures, including use of protease inhibitors and proton pump inhibitors. 
HIV+ People Should Be Able to Receive Organs from HIV+ Donors, Experts Say
- Details
- Category: Liver & Kidney Disease
- Published on Tuesday, 03 July 2012 00:00
- Written by Liz Highleyman
Legislators should lift a federal ban that prevents people with HIV from receiving organs donated by other HIV positive people, experts urged at a Congressional briefing on June 27, 2012.
Compounds in Chocolate and Green Tea May Protect against HIV-related Cognitive Impairment
- Details
- Category: Neurocognitive Problems
- Published on Friday, 17 August 2012 00:00
- Written by Press Release
A set of compounds related to epicatechin, a flavonoid found in cocoa and green tea leaves that easily crosses the blood-brain barrier, can protect against brain cell injury and death caused by HIV proteins in the laboratory, researchers reported in the August 11, 2012, online edition of Journal of NeuroVirology. 
CDC Immunization Committee Recommends 2 Pneumococcal Vaccines for Immunocompromised Adults
- Details
- Category: Opportunistic Illlness (OIs)
- Published on Wednesday, 27 June 2012 00:00
- Written by Liz Highleyman
People with compromised immune systems, including those with advanced HIV disease, should receive a combination of 2 different vaccines to prevent pneumococcal disease, the CDC's Advisory Committee on Immunization Practices (ACIP) recommended at its meeting last week in Atlanta.
More Articles...
- Visceral Fat Reduction in HIV+ People on Tesamorelin Improves Metabolic Profile
- HIV/HCV Coinfected People Have Higher Risk of Hip Fractures
- Young Men on Antiretroviral Therapy at Risk for Bone Loss
- Starting ART below 350 CD4 Cells is Associated with Impaired Artery Function
- Cryptococcal Meningitis Study Halted after Early HIV Treatment Linked to Higher Mortality
HIV/AIDS Topics 















